NMT1 and triple-negative breast carcinoma: We specifically focused our research on triple-negative breast cancer (TNBC) and found that genetic inhibition of NMT1 triggered both ER stress and oxidative stress, and therefore stimulating the JNK pathway to inhibit breast cancer progression.